Scale-first grouping. These guides prioritize classes many people actually use, not only rare high-severity specialist drugs. The first links are quick-start examples; each card then opens a longer set of known examples.
Scale lens: CDC/NCHS reports broad prescription-drug and office-visit drug-therapy use, with analgesics and antihyperlipidemic agents among frequent therapeutic classes; ClinCalc DrugStats adds recent MEPS-derived signals such as statin, GLP-1/GIP, SGLT2, and anticoagulant utilization. CDC/NCHS ยท ClinCalc DrugStats
Statins and Lipid Medicines
High-scale because statins are among the most common chronic medicines; CYP3A, OATP/BCRP transport, fibrates, boosters, macrolides, and azoles can shift muscle-toxicity risk.
Blood Pressure and Heart Failure
Common chronic-care drugs can overlap through potassium, renal function, bradycardia, nitrate/PDE5 hypotension, NSAID blunting, and ACE/ARB/ARNI washout rules.
Anticoagulants and Antiplatelets
High-value because bleeding risk, CYP2C9/VKORC1 context, NSAIDs, SSRIs, azoles, antiplatelet activation, and transporter effects can all overlap.
Diabetes and Weight-Loss Medicines
Scale is rising across metformin, insulin, SGLT2 inhibitors, GLP-1/GIP agents, and common cardiovascular co-meds; useful checks include hypoglycemia masking, metformin exposure, and warfarin changes.
Pain, Inflammation, and Migraine
High-scale because NSAIDs, acetaminophen, opioids, tramadol, migraine medicines, and OTC pain relievers often meet anticoagulants, antidepressants, lithium, methotrexate, and kidney-risk drugs.
Psychiatry, Neurology, Sleep, and OTC Sedating Medicines
Useful for CYP2D6 and CYP2C19 phenotype shifts, QT stacking, serotonin toxicity, anticholinergic burden, seizure threshold, sleep aids, and active-metabolite exceptions.
Antibiotics, Antifungals, and Antivirals
Often interaction-heavy because azoles, macrolides, rifamycins, boosters, and antivirals can strongly inhibit or induce CYP3A4, CYP2C9, P-gp, OATP, or absorption pathways.
Acid Suppression, GI, Minerals, and Binding Interactions
Scale matters because PPIs, H2 blockers, antacids, iron, calcium, binders, thyroid hormone, and antibiotics are common; many misses are absorption/timing rather than CYP.
Contraception, Hormones, and Reproductive Health
High-scale because contraceptives and hormone therapies are common and interaction outcomes include contraceptive failure, seizure destabilization, hormone exposure shifts, and perioperative counseling.
QT Risk, Antiarrhythmics, and Rate Control
Prioritizes narrow-therapeutic-index exposure, QT stacking, CYP2D6 antiarrhythmic metabolism, macrolide or azole inhibition, bradycardia, and electrolyte-sensitive combinations.
Oncology, Immunology, and Transplant
Not the highest-scale outpatient group, but still kept because many drugs have narrow therapeutic windows, prodrug activation, transporter relevance, genotype actionability, and severe inducer sensitivity.